Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNew revision entry v3.3.2 has been added to the record history, and revision v3.2.0 has been removed.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the site-wide government funding operating-status notice from the page; this notice did not pertain to the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check42 days agoChange DetectedNew screenshot shows only a visual/layout update to the Record History page, with the same list of study versions and fields as the old screenshot. There are no observed changes to the underlying study data or version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference11%

- Check78 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating an updated release. The 'Back to Top' link has been removed, a minor UI change.SummaryDifference0.7%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.